Declines and pronounced state-level variation in tapentadol use in the US
Ching Y. Low, Kenneth L. McCall, Brian J. Piper
doi: https://doi.org/10.1101/2022.03.03.22271869
Ching Y. Low
1Geisinger Commonwealth School of Medicine, Scranton, PA, USA
MBSKenneth L. McCall
2University of New England, Portland, ME, USA
PharmDBrian J. Piper
1Geisinger Commonwealth School of Medicine, Scranton, PA, USA
3Center for Pharmacy Innovation & Outcomes, Forty Fort, PA, USA
PhD
- raw DEA data[supplements/271869_file02.pdf]
Posted March 06, 2022.
Declines and pronounced state-level variation in tapentadol use in the US
Ching Y. Low, Kenneth L. McCall, Brian J. Piper
medRxiv 2022.03.03.22271869; doi: https://doi.org/10.1101/2022.03.03.22271869
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)